|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0022671,
umls-concept:C0030705,
umls-concept:C0031327,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0178602,
umls-concept:C0205360,
umls-concept:C0388088,
umls-concept:C0439064,
umls-concept:C0851347,
umls-concept:C0920321
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-10-14
|
|
pubmed:abstractText |
FTY720, a novel immunomodulator, displays potent immunosuppressive activity in a variety of preclinical transplant models. This study examined the safety, pharmacodynamics, and pharmacokinetics of multiple doses of FTY720 in stable renal transplant patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1079-84
|
|
pubmed:dateRevised |
2008-6-5
|
|
pubmed:meshHeading |
pubmed-meshheading:14557756-Adult,
pubmed-meshheading:14557756-Cyclosporine,
pubmed-meshheading:14557756-Dose-Response Relationship, Drug,
pubmed-meshheading:14557756-Double-Blind Method,
pubmed-meshheading:14557756-Drug Administration Schedule,
pubmed-meshheading:14557756-Drug Therapy, Combination,
pubmed-meshheading:14557756-Humans,
pubmed-meshheading:14557756-Immunosuppressive Agents,
pubmed-meshheading:14557756-Kidney Transplantation,
pubmed-meshheading:14557756-Lymphocyte Count,
pubmed-meshheading:14557756-Middle Aged,
pubmed-meshheading:14557756-Placebos,
pubmed-meshheading:14557756-Prednisone,
pubmed-meshheading:14557756-Propylene Glycols,
pubmed-meshheading:14557756-Sphingosine
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
|
|
pubmed:affiliation |
Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX, USA. barry.d.kahan@uth.tmc.edu.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase I
|
